The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy
Open accessAbstract
BACKGROUND: Although high-dose chemotherapy is rapidly gaining acceptance as a treatment option for a number of cancers, the long-term toxic effects of such therapy are a concern. Cognitive deficits (e.g., problems with memory and concentration) are not uncommon after chemotherapy, but they have not been documented systematically. In this study, we assessed the prevalence of cognitive deficits in a group of patients with high-risk breast cancer who were randomly assigned to receive either high-dose or standard-dose adjuvant chemotherapy plus tamoxifen, and we investigated whether high-dose chemotherapy impaired cognitive functioning more than standard-dose chemotherapy. METHODS: Cognitive functioning was evaluated by use of a battery of neuropsychologic tests. In addition, patients were interviewed with regard to cognitive problems, health-related quality of life, anxiety, and depression. Results from patients who received adjuvant systemic therapy were compared with results from patients who had early stage breast cancer not treated with such therapy (control patients). RESULTS: The study population consisted of 34 patients treated with high-dose chemotherapy plus tamoxifen, 36 patients treated with standard-dose chemotherapy plus tamoxifen, and 34 control patients. For all patients, the average time since the completion of last nonhormonal therapy was 2 years. Cognitive impairment was found in 32% of the patients treated with high-dose chemotherapy, in 17% of the patients treated with standard-dose chemotherapy, and in 9% of the control patients. In comparison with the control patients, patients treated with high-dose chemotherapy appeared to have an 8.2-times higher risk of cognitive impairment (odds ratio; 95% confidence interval [CI] = 1.8-37.7); in comparison with the patients who received standard-dose chemotherapy, this risk of impairment was 3.5-times higher (95% CI = 1.0-12.8). CONCLUSION: High-dose chemotherapy appears to impair cognitive functioning more than standard-dose chemotherapy. Central nervous system toxicity may be a dose-limiting factor in high-dose chemotherapy regimens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., Haes, J. C. J. M. D., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.5.365 · Cited by 16,005
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Validity of the Trail Making Test as an Indicator of Organic Brain Damage
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 7,928
L’examen Clinique en Psychologie
Rubé, P. (1959) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1959.13.4.989 · Cited by 3,302
L'examen psychologique ; Dans les cas d'ence-phalopathie traumatique (Les problemes)
Rey, A. (1941) · Medical Entomology and Zoology · Cited by 3,262
(1995) · Cited by 2,809
Benton, A. L. (1994) · Annual Review of Psychology · doi:10.1146/annurev.ps.45.020194.000245 · Cited by 2,307
Wechsler Adult Intelligence Scale
(2007) · Encyclopedia of Measurement and Statistics · doi:10.4135/9781412952644.n478 · Cited by 2,008
Cancer—Principles & Practice of Oncology
Rhoads, J. E. (1983) · PubMed Central · Cited by 1,466
Sapisochin, E. (1962) · PubMed · Cited by 908
Important Advances in Oncology
DeVita, V. T., Hellman, S., & Rosenberg, S. A. (1991) · Anti-Cancer Drugs · doi:10.1097/00001813-199108000-00014 · Cited by 760
Wilson, B., Cockburn, J., Baddeley, A., & Hiorns, R. (1989) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688638908400940 · Cited by 530
Peters, W. P., Ross, M., Vredenburgh, J. J., Meisenberg, B., Marks, L. B., Winer, E., Kurtzberg, J., Bast, R. C., Jones, R., & Shpall, E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1132 · Cited by 501
Le test de copie d'une figure complexe; contribution à l'étude de la perception et de la mémoire.
Osterrieth, P. A. (1944) · Cited by 460
Screening for anxiety and depression in cancer patients: the effects of disease and treatment
Ibbotson, T., Maguire, P., Selby, P., Priestman, T., & Wallace, L. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80015-2 · Cited by 421
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Estrogen Effects on cognition in menopausal women
Sherwin, B. B. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_7.21s · Cited by 290
Important advances in oncology 1994
Holmes, M. E. (1994) · Surgical Oncology · doi:10.1016/0960-7404(94)90075-2 · Cited by 281
Subjective Memory Assessment and Test Performance in Elderly Adults
Sunderland, A., Watts, K., Baddeley, A. D., & Harris, J. E. (1986) · Journal of Gerontology · doi:10.1093/geronj/41.3.376 · Cited by 250
Memory failures in everyday life following severe head injury
Sunderland, A., Harris, J. E., & Gleave, J. (1984) · Journal of Clinical Neuropsychology · doi:10.1080/01688638408401204 · Cited by 249
Hormones, mood, and cognitive functioning in postmenopausal women
SHERWIN, B. (1996) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00431-9 · Cited by 213
What do cancer patients mean when they complain of concentration and memory problems?
Cull, A., Hay, C., Love, S., Mackie, M., Smets, E., & Stewart, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.608 · Cited by 200
Eddy, D. M. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.657 · Cited by 174
Cognitive deficits in patients with small cell lung cancer before and after chemotherapy
Meyers, C. A., Byrne, K. S., & Komaki, R. K. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00446-8 · Cited by 166
Meyers, C. A., Weitzner, M. A., Byrne, K., Valentine, A., Champlin, R. E., & Przepiorka, D. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.820 · Cited by 151
Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.
Devlen, J., Maguire, P., Phillips, P. H., & Crowther, D. (1987) · BMJ · doi:10.1136/bmj.295.6604.955 · Cited by 145
Arpels, J. C. (1996) · PubMed · Cited by 139
Silberfarb, P. M., Philibert, D., & Levine, P. M. (1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.5.597 · Cited by 138
Memory complaints in epilepsy: correlations with cognitive performance and neuroticism
Vermeulen, J., Aldenkamp, A. P., & Alpherts, W. C. J. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90096-p · Cited by 126
Multiple contrasts and ordered Bonferroni procedures.
Rosenthal, R., & Rubin, D. B. (1984) · Journal of Educational Psychology · doi:10.1037//0022-0663.76.6.1028 · Cited by 88
Psychosocial aspects of neoplastic disease
Silberfarb, P. M., & Levine, P. M. (1980) · General Hospital Psychiatry · doi:10.1016/0163-8343(80)90061-4 · Cited by 85
Cognitive functioning in cancer patients
Meyers, C. A., & Abbruzzese, J. L. (1992) · Neurology · doi:10.1212/wnl.42.2.434 · Cited by 85
Psychologic and neuropsychologic impact of autologous bone marrow transplantation.
Ahles, T. A., Tope, D. M., Furstenberg, C. T., Hann, D. M., & Mills, L. E. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1457 · Cited by 85
Cited by
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationCandidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
(2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.13.979 · Cited by 893
Cognitive deficits in adult patients with brain tumours
Taphoorn, M. J., & Klein, M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00680-5 · Cited by 756
Prevalence, mechanisms, and management of cancer-related cognitive impairment
Janelsins, M. C., Kesler, S. R., Ahles, T. A., & Morrow, G. R. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864260 · Cited by 745
Metadata
- Authors
- van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02-04
- Volume
- 90
- Issue
- 3
- Pages
- 210-218
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2106431827
- Cited by
- 763
- References
- 34
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.